STOCK TITAN

Lipocine (LPCN): Squadron funds report 810,000 shares, a 9.8% ownership stake

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Squadron Master Fund LP and related parties report a significant ownership stake in Lipocine Inc. The group, including Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank, reports beneficial ownership of 810,000 shares of Lipocine common stock, representing 9.8% of the outstanding shares, based on 8,244,253 shares outstanding as of May 6, 2026. Voting and dispositive power over these shares is reported as shared, with no sole voting or dispositive power. The reporting persons state that the Funds have the right to receive dividends and sale proceeds and expressly disclaim beneficial ownership under Rule 13d-4.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 810,000 shares Common Stock of Lipocine Inc. reported by each filer
Percent of class 9.8% Ownership percentage of Lipocine common stock for each reporting person
Shares outstanding 8,244,253 shares Lipocine common stock outstanding as of May 6, 2026
Sole voting power 0 shares Sole power to vote Lipocine common stock reported by each filer
Shared voting power 810,000 shares Shared power to vote or direct the vote for each reporting person
beneficial owner financial
"may be deemed to be the beneficial owner of all shares of Common Stock"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting power financial
"Shared Voting Power 810,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 810,000.00"
Investment Advisers Act of 1940 regulatory
"an investment adviser that is registered under the Investment Advisers Act of 1940"
A U.S. federal law that sets rules for people and firms who give investment advice, requiring them to register with regulators, be honest about conflicts, keep records, and follow basic standards of care. It matters to investors because those rules act like licensing and consumer protections — similar to having safety standards for a mechanic — helping ensure advisers act in clients’ financial interests and reducing the risk of fraud or misuse of funds.
Rule 13d-4 regulatory
"Pursuant to Rule 13d-4 , as amended, Squadron Capital Management, LLC"
Schedule 13G regulatory
"If a parent holding company has filed this schedule, pursuant to (ii)(G)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What ownership stake in Lipocine Inc. (LPCN) does Squadron Master Fund report?

Squadron Master Fund LP and related parties report beneficial ownership of 810,000 shares of Lipocine common stock, representing 9.8% of the class, based on 8,244,253 shares outstanding as of May 6, 2026.

Who are the reporting persons in this Lipocine (LPCN) Schedule 13G/A?

The reporting persons are Squadron Master Fund LP, Squadron Capital Management, LLC, and individuals Matthew Sesterhenn and William Blank, all reporting the same 810,000 shares and 9.8% ownership stake in Lipocine.

How much voting power do the Squadron entities have in Lipocine (LPCN)?

The reporting persons state they have 0 shares of sole voting power and 810,000 shares of shared voting power in Lipocine common stock, matching their reported beneficial ownership position.

On what share count is the 9.8% Lipocine (LPCN) ownership based?

The 9.8% ownership figure is calculated using 8,244,253 shares of Lipocine common stock outstanding as of May 6, 2026, as reported by Lipocine on its Form 10-Q filed May 7, 2026.

Do the Squadron filers disclaim beneficial ownership of Lipocine (LPCN) shares?

Yes. Squadron Capital Management, LLC and Messrs. Sesterhenn and Blank expressly disclaim beneficial ownership of the securities reported, citing Rule 13d-4, even though they may be deemed beneficial owners through their roles.

Who receives dividends and sale proceeds from the Lipocine (LPCN) shares?

The filing states that the Funds have the right to receive, or direct the receipt of, dividends and sale proceeds from the 810,000 shares of Lipocine common stock covered by the statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





53630X203

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Squadron Master Fund LP
Signature:/s/ Matthew Sesterhenn
Name/Title:Partner, Squadron Partners LLC, its General Partner
Date:08/14/2026
Squadron Capital Management LLC
Signature:/s/ Matthew Sesterhenn
Name/Title:Partner
Date:08/14/2026
Matthew Sesterhenn
Signature:/s/ Matthew Sesterhenn
Name/Title:Matthew Sesterhenn
Date:08/14/2026
William Blank
Signature:/s/ William Blank
Name/Title:William Blank
Date:08/14/2026